Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CHKA | P35790 | 4/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 2/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20143116 | 0.89 | RXRA (0.41) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL18775303 | 0.83 | PKM (0.44) | RAB9AACHERXRARXRBRXRG | |
| SCHEMBL18775290 | 0.82 | KDM4E (0.56) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL18775299 | 0.80 | MRGPRX4 (0.46) | KDM4ECYP1A2CYP2D6 | |
| SCHEMBL20143526 | 0.79 | RXRA (0.44) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL18775292 | 0.79 | KDM4E (0.58) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL19102940 | 0.77 | ACHE (0.41) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL14570493 | 0.74 | IDO1 (0.43) | GRIN2BIDH1TACR1NOS3NOS1 | |
| SCHEMBL18775287 | 0.74 | BCHE (0.58) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL16767879 | 0.73 | GRIN2B (0.44) | GRIN2BIDH1NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969931-B2 | Electrochromic composition and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | SCN11A, ECH1, H1-0 | KDM4E 1299/4885ALDH1A1 656/4885RAB9A 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.